176 related articles for article (PubMed ID: 33404753)
1. Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing.
Trkulja V
Eur J Clin Pharmacol; 2021 Jun; 77(6):935-937. PubMed ID: 33404753
[No Abstract] [Full Text] [Related]
2. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.
Kow CS; Aldeyab M; Hasan SS
J Med Virol; 2021 Apr; 93(4):1860-1861. PubMed ID: 33118617
[No Abstract] [Full Text] [Related]
3. Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.
Yang CJ; Wei YJ; Chang HL; Chang PY; Tsai CC; Chen YH; Hsueh PR
J Microbiol Immunol Infect; 2021 Feb; 54(1):27-36. PubMed ID: 33060041
[TBL] [Abstract][Full Text] [Related]
4. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
Camprubí D; Gaya A; Marcos MA; Martí-Soler H; Soriano A; Mosquera MDM; Oliver A; Santos M; Muñoz J; García-Vidal C
Int J Infect Dis; 2021 Mar; 104():379-381. PubMed ID: 33359065
[TBL] [Abstract][Full Text] [Related]
5. BET 1: The role of remdesivir in COVID-19 infection.
Baombe JP
Emerg Med J; 2020 Aug; 37(8):522-523. PubMed ID: 32753375
[TBL] [Abstract][Full Text] [Related]
6. Timing of remdesivir for COVID-19.
Med Lett Drugs Ther; 2020 Oct; 62(1609):161. PubMed ID: 33429407
[No Abstract] [Full Text] [Related]
7. Update Alert 2: Remdesivir for Adults With COVID-19.
Kaka AS; MacDonald R; Linskens EJ; Wilt TJ
Ann Intern Med; 2021 Dec; 174(12):W114-W115. PubMed ID: 34606312
[No Abstract] [Full Text] [Related]
8. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Trials; 2020 May; 21(1):422. PubMed ID: 32448345
[TBL] [Abstract][Full Text] [Related]
9. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
10. Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019.
Dellapiana G; Naqvi M; Leggett C; Tholemeier L; Burwick RM
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100218. PubMed ID: 32844157
[No Abstract] [Full Text] [Related]
11. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center.
McCoy JA; Short WR; Srinivas SK; Levine LD; Hirshberg A
Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100164. PubMed ID: 32838267
[No Abstract] [Full Text] [Related]
12. Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients.
Odeti S; Yellepeddi VK
Am Fam Physician; 2021 Sep; 104(3):311-312. PubMed ID: 34523893
[No Abstract] [Full Text] [Related]
13. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.
Wu TY; Chen PY; Wang JT; Liu WD; Chen YC; Chang SC
J Antimicrob Chemother; 2024 May; 79(5):1196-1200. PubMed ID: 38538154
[No Abstract] [Full Text] [Related]
15. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
[TBL] [Abstract][Full Text] [Related]
16. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL;
Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308
[No Abstract] [Full Text] [Related]
17. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R; Kansagara DL; Marcucci M
Ann Intern Med; 2021 Feb; 174(2):229-236. PubMed ID: 33017175
[TBL] [Abstract][Full Text] [Related]
18. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
Naqvi M; Zakowski P; Glucksman L; Smithson S; Burwick RM
Obstet Gynecol; 2020 Nov; 136(5):1025-1029. PubMed ID: 32618794
[TBL] [Abstract][Full Text] [Related]
20. Remdesivir (Veklury) for COVID-19.
Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
